# EDGAR Filing Document

**Accession Number:** 0000008146
**File Stem:** 0001193125-26-260672
**Filing Date:** 2026-6
**Character Count:** 68877
**Document Hash:** 0600143598b66a18e4f78a3e20442dc6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-260672.hdr.sgml**: 20260608

**ACCESSION NUMBER**: 0001193125-26-260672

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 21

**CONFORMED PERIOD OF REPORT**: 20260608

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260608

**DATE AS OF CHANGE**: 20260608

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AstroNova, Inc.
- **CENTRAL INDEX KEY:** 0000008146
- **STANDARD INDUSTRIAL CLASSIFICATION:** COMPUTER PERIPHERAL EQUIPMENT, NEC [3577]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 050318215
- **STATE OF INCORPORATION:** RI
- **FISCAL YEAR END:** 0131

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-13200
- **FILM NUMBER:** 261071010

**BUSINESS ADDRESS:**
- **STREET 1:** 600 E GREENWICH AVENUE
- **CITY:** WEST WARWICK
- **STATE:** RI
- **ZIP:** 02893
- **BUSINESS PHONE:** 4018284000

**MAIL ADDRESS:**
- **STREET 1:** 600 E GREENWICH AVENUE
- **CITY:** WEST WARWICK
- **STATE:** RI
- **ZIP:** 02893

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ASTRO MED INC /NEW/
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ATLAN TOL INDUSTRIES INC
- **DATE OF NAME CHANGE:** 19850220

?xml version='1.0' encoding='ASCII'? 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

### FORM 8-K

#### CURRENT REPORT

#### Pursuant to Section 13 OR 15(d)

#### of The Securities Exchange Act of 1934

#### Date of report (Date of earliest event reported): June 8, 2026

## ASTRONOVA, INC.

#### (Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Rhode Island** | **0-13200** | **05-0318215** |
| **(State or other jurisdiction** | **(Commission** | **(I.R.S. Employer** |
| **of incorporation)** | **File Number)** | **Identification No.)** |

---

---

| |
|:---|
| **600 East Greenwich Avenue** |
| **West Warwick, RI 02893** |
| **(Address of principal executive offices) (Zip Code)** |

---

(401) 828-4000

#### Registrant's telephone number, including area code

#### Not applicable

#### (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading**<br> **Symbol(s)** | **Name of Each Exchange**<br> **on which Registered** |
| Common Stock, $0.05 Par Value | ALOT | NASDAQ Global Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 2.02** | **Results of Operations and Financial Condition.**  |

---

On June 8, 2026, we issued a press release reporting the financial results for our fiscal first quarter ended April 30, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information contained in Item 2.02 of this report and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statement and Exhibits.**  |

---

(d) Exhibits

---

| | |
|:---|:---|
| **Exhibit No.** | **Exhibit** |
| 99.1 | [Press Release dated June 8, 2026](d36739dex991.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **ASTRONOVA, INC.** | **ASTRONOVA, INC.** |
| Dated: June 8, 2026 | By: | /s/ Thomas D. DeByle |
|  |  | Thomas D. DeByle |
|  |  | Vice President, Chief Financial Officer and Treasurer |

---

## Exhibit 99.1

**Exhibit 99.1** 

---

| | |
|:---|:---|
| ![LOGO](g36739dsp01.jpg) | ![LOGO](g36739dsp01a.jpg) |

---

FOR IMMEDIATE RELEASE

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Revenue increased $1.7 million to $39.4 million driven by Aerospace sales growth of 16.3%* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Consolidated operating profit grew to $1.6 million and operating margin expanded 250 bps to 4.0%* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Net income increased $1.0 million year-over-year to $0.7 million, or $0.08 per diluted share, compared with prior-year loss; Adjusted EBITDA increased 31.0% to $4.1 million* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Total orders in the quarter were up 32.6% to $46.3 million for a book-to-bill ratio of 118%* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Total debt of $35.9 million was reduced by $8.8 million compared with the first quarter of fiscal 2026 and $1.7 million compared with the fourth quarter of fiscal 2026; net debt of $31.2 million was down $2.3 million in the quarter compared with the fourth quarter of fiscal 2026* 

**West Warwick, R.I., June 8, 2026** – <u>AstroNova, Inc.</u> (Nasdaq: ALOT), a leading innovator in specialized print technology solutions, today announced financial results for its fiscal 2027 first quarter ended April 30, 2026.

Jorik Ittmann, President and Chief Executive Officer of AstroNova, stated, "We had a solid start to fiscal 2027, with revenue increasing over 4% while operating profit grew over 170%. Our ToughWriter<sup>®</sup> branded flight deck printer is now the predominant product sold by our Aerospace segment. As a result, we had higher volume combined with improved pricing which drove profitability for that segment. In addition, our Product ID progress continues to strengthen its sales, marketing and operations with upgraded talent and an ever more sophisticated, customer-centric approach to the business. We are encouraged by our momentum and remain confident in the outlook for a strong year."

**First Quarter Fiscal 2027 Overview**<sup>1</sup> *(comparisons are to the prior-year period unless noted otherwise)* 

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
|  | **April 30,<br>2026** | April 30,<br>2025 | **$Variance** | **%<br>Variance** |
|  Revenue | $39364 | $37708 | $1656 | 4.4% |
|  Gross Profit | $14425 | $11951 | $2474 | 20.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Gross Profit Margin* | *36.6 %* | *31.7 %* |  |  |
|  Non-GAAP Gross Profit | $14552 | $12352 | $2200 | 17.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Non-GAAP Adjusted Gross Profit Margin* | *36.9 %* | *32.8 %* |  |  |
|  Operating Income (Loss) | $1562 | $571 | $991 | 173.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Operating Margin* | *4.0 %* | *1.5 %* |  |  |
|  Non-GAAP Operating Income | $2589 | $1527 | $1062 | 69.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Non-GAAP Operating Income Margin* | *6.6 %* | *4.0 %* |  |  |
|  Net Income (Loss) | $653 | $(376) | $1029 | (273.5)% |
|  Non-GAAP Net Income (Loss) | $1443 | $354 | $1089 | 307.8% |
|  Adjusted EBITDA | $4122 | $3148 | $974 | 30.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *Adjusted EBITDA Margin* | *10.5 %* | *8.3 %* |  |  |

---

*<sup>1</sup>* *Non-GAAP gross profit, Non-GAAP gross profit margin, Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP net income, adjusted EBITDA and adjusted EBITDA margin are Non-GAAP financial measures. Refer to the reconciliation of GAAP to non-GAAP measures in the tables that accompany this news release.* 

-MORE-

AstroNova Inc. \| 600 East Greenwich Avenue \| West Warwick, RI 02893 \| 401.828.4000

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 2 of 16** 

Compared with the prior-year period, revenue increased $1.7 million, or 4.4%, driven by Aerospace segment growth that was marginally offset by a slight decline in Product ID revenue. Tariff mitigation contributed $0.7 million in revenue and foreign currency translation was a $0.6 million benefit to revenue in the quarter.

Gross profit increased $2.5 million, or 20.7%, and gross margin expanded 490 basis points to 36.6% primarily reflecting higher Aerospace volume and favorable mix. On an adjusted basis, excluding restructuring charges of $0.4 million and a $0.3 million net inventory reserve reversal, gross margin expanded 410 basis points from the prior-year to 36.9%.

Operating expenses in the quarter of $12.9 million included $0.7 million of non-recurring legal and professional fees. Higher gross profit combined with cost containment initiatives resulted in operating income increasing $1.0 million to $1.6 million in the quarter while operating margin expanded 250 basis points. Excluding non-recurring items, non-GAAP operating income increased 69.5% to $2.6 million compared with the prior-year period.

Interest expense of $0.7 million decreased $0.2 million from the prior-year period, reflecting lower outstanding debt. Net income grew to $0.7 million, or $0.08 per diluted share, compared with a net loss in the prior-year period. Non-GAAP net income increased to $1.4 million, or $0.19 per share, as a result of the improved performance in the quarter. Adjusted EBITDA was $4.1 million and Adjusted EBITDA margin was 10.5%.

**Aerospace Segment Review** 

Aerospace segment revenue grew $1.9 million, or 16.3%, to $13.3 million compared with the prior year. Growth was driven by higher hardware volume and favorable product mix as commercial OEM production rates continued to increase. Aerospace hardware revenue grew 37.9% to $9.0 million year-over-year reflecting continued conversion to the ToughWriter<sup>®</sup> platform.

Aerospace segment operating profit increased $1.9 million, or 96%, to $3.9 million driven by improved volume and pricing. Non-GAAP segment operating income was $3.4 million, or 25.6% of revenue, compared with $2.2 million in the prior-year period.

Orders in the quarter for the Aerospace segment increased 125.1% to $19.5 million for a book-to-bill ratio of 147% reflecting strong demand from OEMs for new build aircraft. Backlog at the end of the first quarter was $18.2 million, an increase of $6.2 million from the end of fiscal 2026 and more than double the $7.4 million at the end of the prior-year period.

**Product Identification (Product ID) Segment Review** 

Product ID revenue was $26.1 million for the first quarter of fiscal 2027, down 0.8%, or $0.2 million, compared with the prior year. Hardware revenue increased modestly on new customer acquisition while recurring revenue was down $0.2 million. Recurring revenue represented approximately 82% of total segment sales. The year-over-year decline in direct-to-package revenue reflects the planned migration from legacy Trojan-platform products to MTEX-based solutions that the Company expects to begin to ramp in the second quarter of fiscal 2027.

Product ID segment operating income was $0.6 million, double over the prior-year period, reflecting improving productivity, better cost control and favorable aftermarket mix. Non-GAAP segment operating income was $1.3 million, or 4.8% of revenue, compared with $1.0 million in the prior-year period.

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 3 of 16** 

Orders in the quarter for the Product ID segment increased $0.5 million, or 2.1%, to $26.8 million compared with the prior-year period. The book-to-bill ratio for the segment was 103% and backlog at the end of the first quarter was $14.2 million.

**Balance Sheet and Cash Flow** 

Cash from operations in the first quarter of fiscal 2027 was $3.0 million compared with $4.4 million in the prior year period as stronger cash earnings were offset by higher working capital requirements due to timing of receivables from customers and inventory requirements to support growth.

Capital expenditures in the quarter were $36 thousand compared with $60 thousand in the prior year.

Cash at the end of the first quarter of fiscal 2027 was $4.7 million compared with $4.1 million at the end of fiscal 2026. Net debt as of April 30, 2026, was $31.2 million, a reduction of $2.3 million, or 6.9%, compared with the end of the fourth quarter of fiscal 2026.

**Earnings Conference Call Information** 

AstroNova will host a conference call and webcast at 8:15 a.m. ET on Monday, June 8, 2026, to review financial and operating results for the first quarter of fiscal 2027. A question and answer session will follow.

To access the conference call, please dial (201) 689-8560 or find the webcast and accompanying slide presentation at <u>https://investors.astronovainc.com/investors/events-and-presentations/default.aspx.</u>

A telephonic replay will be available from 12:00 p.m. ET on the day of the call through Monday, June 22, 2026. To listen to the archived call, dial (412) 317-6671 and enter a replay PIN 13760545. The webcast replay will be available on the <u>Investor Relations</u> section of the Company's website where a transcript will be posted once available.

**About AstroNova, Inc.** 

AstroNova (Nasdaq: ALOT) is a global provider of printing technologies serving regulated and industrial markets. The Company designs, manufactures, distributes, and services solutions that enable customers to identify, track, and communicate essential product and safety information across a wide range of applications and media. AstroNova supports customers by enabling safety, accuracy and durability for flight deck communications, medical device and healthcare products, essential chemical products, and mission-critical industrial components, while ensuring compliance with local and regional regulatory requirements.

The Product Identification segment delivers end-to-end marking and identification solutions, including hardware, software, and consumables for OEMs, commercial printers, and brand owners. These solutions are used across labels, flexible packaging, corrugated, and industrial substrates, where durability, traceability, and compliance are essential. The Aerospace segment is a global leader in providing products designed for airborne printing solutions, avionics, and data acquisition, including flight deck printing solutions, networking hardware, and specialized aerospace-grade supplies. For more information please visit: <u>www.astronovainc.com.</u>

**Use of Non-GAAP Financial Measures** 

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this news release contains the Non-GAAP financial measures: Non-GAAP gross profit, Non-GAAP gross profit margin, Non-GAAP operating expenses, Non-GAAP operating income, Non-GAAP operating income margin, Non-GAAP net income (loss), Non-GAAP net income per Common Share—diluted, Non-GAAP segment gross profit, Non-GAAP segment gross profit margin, Non-GAAP segment operating income,

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 4 of 16** 

Non-GAAP segment operating margin, Adjusted EBITDA and Adjusted EBITDA Margin. AstroNova believes that the inclusion of these Non-GAAP financial measures helps investors gain a meaningful understanding of changes in the Company's core operating results and can help investors who wish to make comparisons between AstroNova and other companies on both a GAAP and a Non-GAAP basis. AstroNova's management uses these Non-GAAP financial measures, in addition to GAAP financial measures, as the basis for measuring its core operating performance and comparing such performance to that of prior periods and to the performance of its competitors. These measures are also used by the Company's management to assist with their financial and operating decision-making. Please refer to the financial reconciliation table included in this news release for a reconciliation of the Non-GAAP measures to the most directly comparable GAAP measures for the three months ended April 30, 2026 and 2025.

**Forward-Looking Statements** 

Information included in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact but rather reflect our current expectations concerning future events and results. These statements may include the use of the words "believes," "expects," "intends," "plans," "anticipates," "likely," "continues," "may," "will," and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning the Company's anticipated performance, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, (i) the risk that our efforts to improve sales in our Product Identification segment may not result in the benefits we expect, (ii) the risk that our Aerospace customers may not continue to convert to our ToughWriter<sup>®</sup> printer in the volumes or on the schedule that we expect; (iii) the risk that we may not realize the anticipated benefits of our next-generation print engine technology; and (iv) those factors set forth in the Company's Annual Report on Form 10-K for the fiscal year ended January 31, 2026 and subsequent filings AstroNova makes with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The reader is cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this news release.

**Contact:** 

Deborah Pawlowski, IRC, Alliance Advisors

Email: <u>dpawlowski@allianceadvisors.com</u>

Phone: 716.843.3908

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 5 of 16** 

**ASTRONOVA, INC.** 

**Condensed Consolidated Statements of Income (Loss)** 

**In Thousands Except for Per Share Data** 

**(Unaudited)** 

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended | Three Months Ended | | |
|  | **April 30,<br>2026** | April 30,<br>2025 |<br>**$ Variance** |<br>**%**<br>**Variance** |
|  Revenue | $**39364** | $37708 | $1656 | 4.4% |
|  Cost of Revenue | **24939** | 25757 | (818) | (3.2)% |
|  Gross Profit | **14425** | 11951 | 2474 | 20.7% |
|  *Total Gross Profit Margin* | *36.6 %* | *31.7 %* |  |  |
|  Operating Expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Selling & Marketing | **5692** | 5605 | 87 | 1.6% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Research & Development | **1809** | 1529 | 280 | 18.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; General & Administrative | **5363** | 4246 | 1117 | 26.3% |
|  Total Operating Expenses | **12864** | 11380 | 1484 | 13.0% |
|  Operating Income | **1562** | 571 | 991 | 173.7% |
|  *Total Operating Margin* | *4.0 %* | *1.5 %* |  |  |
|  Interest Expense | **675** | 897 | (222) | (24.7)% |
|  Other (Income)/Expense, net | **38** | (25) | 63 | (250.0)% |
|  Income (Loss) Before Taxes | **849** | (301) | 1150 | (381.7)% |
|  Income Tax Provision | **196** | 75 | 121 | 161.3% |
|  Net Income (Loss) | $**653** | $(376) | $1029 | (273.5)% |
|  Net Income (Loss) per Common Share - Basic | $**0.09** | $(0.05) |  |  |
|  Net Income (Loss) per Common Share - Diluted | $**0.08** | $(0.05) |  |  |
|  Weighted Average Number of Common Shares - Basic | **7678** | 7560 |  |  |
|  Weighted Average Number of Common Shares - Diluted | **7774** | 7560 |  |  |

---

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 6 of 16** 

**ASTRONOVA, INC.** 

**Condensed Consolidated Balance Sheets** 

**In Thousands** 

**(Unaudited)** 

---

| | | |
|:---|:---|:---|
|  | **April 30,<br>2026** | Jan 31,<br>2026 |
|  ASSETS |  |  |
|  CURRENT ASSETS |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash and Cash Equivalents | $**4675** | $4072 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts Receivable, net | **21627** | 18985 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventories, net | **43926** | 43252 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prepaid Expenses and Other Current Assets | **4425** | 4395 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Current Assets | **74653** | 70704 |
|  PROPERTY, PLANT AND EQUIPMENT | **40364** | 40400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Less Accumulated Depreciation | **(26718)** | (26272) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Property, Plant and Equipment, net | **13646** | 14128 |
|  OTHER ASSETS |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Identifiable Intangibles, net | **20684** | 21496 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Goodwill | **17244** | 17376 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred Tax Assets, net | **9780** | 9831 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Right of Use Asset | **2307** | 2466 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Assets | **1542** | 1565 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **TOTAL ASSETS** | $**139856** | $137566 |
|  LIABILITIES AND SHAREHOLDERS' EQUITY |  |  |
|  CURRENT LIABILITIES |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts Payable | $**7601** | $6806 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued Compensation | **4673** | 4390 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Accrued Expenses | **7564** | 4702 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Revolving Line of Credit | **15398** | 16273 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current Portion of Long-Term Debt | **4272** | 3033 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current Liability – Royalty Obligation | **1233** | 1656 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current Liability – Excess Royalty Payment Due | **194** | 331 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income Taxes Payable | **1036** | 691 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred Revenue | **393** | 489 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Current Liabilities | **42364** | 38371 |
|  NON-CURRENT LIABILITIES |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Long-Term Debt, net of current portion | **16234** | 18295 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lease Liabilities, net of current portion | **1784** | 1953 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Grant Deferred Revenue | **926** | 899 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Royalty Obligation, net of current portion | **160** | 145 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income Tax Payables | **800** | 800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Long-Term Liability | **66** | 241 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **TOTAL LIABILITIES** | **62334** | 60704 |
|  SHAREHOLDERS' EQUITY |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common Stock | **558** | 554 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Additional Paid-in Capital | **66889** | 66329 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Retained Earnings | **47657** | 47004 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treasury Stock | **(35418)** | (35227) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accumulated Other Comprehensive Loss, net of tax | **(2164)** | (1798) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **TOTAL SHAREHOLDERS' EQUITY** | **77522** | 76862 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY** | $**139856** | $137566 |

---

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 7 of 16** 

**ASTRONOVA, INC.** 

**Condensed Consolidated Statements of Cash Flows** 

**(In Thousands)** 

**(Unaudited)** 

---

| | | |
|:---|:---|:---|
|  | Three Months Ended | Three Months Ended |
|  | **April 30, 2026** | April 30, 2025 |
|  **Cash Flows from Operating Activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net Income (Loss) | $653 | $(376) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depreciation and Amortization | 1182 | 1290 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Grant Income Included in Depreciation | 69 | 56 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization of Debt Issuance Costs | 10 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Share-Based Compensation | 389 | 306 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred Income Tax Provision (Benefit) | 37 | (52) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in Assets and Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts Receivable | (2691) | 210 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventories | (766) | (2704) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income Taxes | 146 | 172 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accounts Payable and Accrued Expenses | 3902 | 3622 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred Revenue | (73) | 1041 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other | 163 | 822 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net Cash Provided by Operating Activities | 3021 | 4395 |
|  **Cash Flows from Investing Activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchases of Property, Plant and Equipment | (36) | (60) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net Cash Used for Investing Activities | (36) | (60) |
|  **Cash Flows from Financing Activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net Cash Proceeds from Share Purchases under Employee Stock Purchase Plan |  | 51 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net Cash Used for Payment of Taxes Related to Vested Restricted Stock | (191) | (155) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Revolving Credit Facility, net | (824) | (2872) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Payment of Minimum Guarantee Royalty Obligation | (423) | (428) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Principal Payments of Long-Term Debt | (809) | (826) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net Cash Provided by (Used for) Financing Activities | (2247) | (4230) |
|  Effect of Exchange Rate Changes on Cash and Cash Equivalents | (135) | 198 |
|  Net Increase in Cash and Cash Equivalents | 602 | 303 |
|  Cash and Cash Equivalents, Beginning of Period | 4072 | 5050 |
|  **Cash and Cash Equivalents, End of Period** | $**4675** | $**5353** |
|  Supplemental Information: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash Paid (Received) During the Period for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest | $652 | $770 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Income Taxes, net of refunds | $50 | $(100) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-Cash Transactions: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating Lease Obtained in Exchange for Operating Lease Liabilities | $— | $936 |

---

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 8 of 16** 

**ASTRONOVA, INC.** 

**Segment Sales and Profit** 

*(Unaudited, $ in thousands)* 

---

| | | |
|:---|:---|:---|
|  | **Three Months<br>Ended** | **Three Months<br>Ended** |
| ($ in thousands) | **April 30,<br>2026** | April 30,<br>2025 |
|  **Revenue:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product ID | $**26089** | $26289 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aerospace | **13275** | 11419 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Revenue | $**39364** | $37708 |
|  **Gross Profit:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product ID | $**8403** | $8233 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aerospace | **6022** | 3718 |
|  Gross Profit | $**14425** | $11951 |
|  **Gross Profit Margin:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product ID | **32.2%** | 31.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aerospace | **45.4%** | 32.6% |
|  Gross Profit Margin | **36.6%** | 31.7% |
|  **Segment Operating Income:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product ID | $**566** | $260 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aerospace | **3878** | 1979 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Segment Operating Income | $**4444** | $2239 |
|  **Segment Operating Margin:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product ID | **2.2%** | 1.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aerospace | **29.2%** | 17.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Segment Operating Margin | **11.3%** | 5.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corporate Expense | **(2882)** | (1668) |
|  Operating Income (Loss) | $**1562** | $571 |
|  Interest Expense | **675** | 897 |
|  Other (Income)/Expense, net | **38** | (25) |
|  Income (Loss) Before Income Taxes | $**849** | $(301) |
|  Income Tax Provision (Benefit) | **196** | 75 |
|  Net Income (Loss) | $**653** | $(376) |

---

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 9 of 16** 

**ASTRONOVA, INC.** 

**Segment Sales and Non-GAAP Profit** 

*(Unaudited, $ in thousands)* 

---

| | | |
|:---|:---|:---|
|  | **Three Months<br>Ended** | **Three Months<br>Ended** |
| ($ in thousands) | **April 30,<br>2026** | April 30,<br>2025 |
|  **Revenue:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product ID | $**26089** | $26289 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aerospace | **13275** | 11419 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Revenue | $**39364** | $37708 |
|  **Gross Profit:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product ID | $**9023** | $8465 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aerospace | **5527** | 3887 |
|  Non-GAAP Gross Profit | $**14550** | $12352 |
|  **Gross Profit Margin:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product ID | **34.6%** | 32.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aerospace | **41.6%** | 34.0% |
|  Non-GAAP Gross Profit Margin | **36.9%** | 32.8% |
|  **Segment Operating Income:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product ID | $**1263** | $995 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aerospace | **3393** | 2150 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Non-GAAP Segment Operating Income | $**4656** | $3145 |
|  **Segment Operating Margin:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Product ID | **4.8%** | 3.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aerospace | **25.6%** | 18.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Non-GAAP Segment Operating Margin | **11.8%** | 8.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corporate Expense | (2067) | (1620) |
|  Non-GAAP Operating Income | $**2589** | $1527 |
|  Interest Expense | $**675** | $897 |
|  Other (Income)/Expense, net | **38** | (25) |
|  Income Before Income Taxes | $**1876** | $655 |
|  Adjusted Income Tax Provision (Benefit) | **433** | 301 |
|  Non-GAAP Net Income | $**1443** | $354 |

---

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 10 of 16** 

**ASTRONOVA, INC.** 

**Revenue by Market** 

*(in thousands)*

*(unaudited)*

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| ***Product ID:*** | **Q1 FY26** | **Q2 FY26** | **Q3 FY26** | **Q4 FY26** | **FY2026** | **Q1 FY27** | **YTD FY2027** |
|  Desktop Label Printers | $15478 | $15190 | $16115 | 15041 | 61824 | $15466 | 15466 |
|  Mail & Sheet/Flat Pack Printers | 4050 | 3740 | 4280 | 4138 | 16208 | 4095 | 4095 |
|  Professional Label Printers | 3247 | 3506 | 3636 | 3863 | 14252 | 3503 | 3503 |
|  Direct to Package/Overprint Printers | 3396 | 2230 | 2371 | 2579 | 10576 | 2248 | 2248 |
|  Flexible Packaging Printers | 30 | 69 | 79 | 38 | 216 | 47 | 47 |
|  Other | 88 | 19 | 368 | 670 | 1145 | 731 | 731 |
|  **TOTAL** | $**26289** | $**24754** | $**26849** | **26329** | **104221** | $**26089** | **26089** |
| ***Aerospace:*** | **Q1 FY26\*** | **Q2 FY26** | **Q3 FY26** | **Q4 FY26** | **FY2026** | **Q1 FY27** | **YTD FY2027** |
|  Commercial Aircraft | $4953 | $4714 | $5764 | $5030 | $20461 | $7247 | $7247 |
|  Aftermarket | 4911 | 4953 | 4955 | 4831 | 19650 | 4275 | 4275 |
|  Defense | 811 | 1047 | 766 | 885 | 3509 | 754 | 754 |
|  Regional and Biz Jet Aircraft | 396 | 431 | 634 | 195 | 1656 | 564 | 564 |
|  Other | 348 | 203 | 201 | 266 | 1018 | 435 | 435 |
|  **TOTAL** | $**11419** | $**11348** | $**12320** | $**11207** | $**46294** | $**13275** | $**13275** |
|  **Consolidated Total** | $**37708** | $**36102** | $**39169** | **37536** | **150515** | $**39364** | **39364** |

---

\* Q1 fiscal 2026 revenue by market has been revised from amount previously reported in our Q1 fiscal 2026 press release issued on June 5, 2025, to correct a classification error between market categories. Total Q1 2026 fiscal sales were unaffected. 

**ASTRONOVA, INC.** 

**Revenue by Type** 

*(Unaudited, $ in thousands)*

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Q1 FY26** | **Q2 FY26** | **Q3 FY26** | **Q4 FY26** | **FY 2026** | **Q1 FY27** | **YTD FY2027** |
|  **Product ID** |  |  |  |  |  |  |  |
|  Product ID HW | $4776 | $4511 | $5357 | $5332 | $19976 | $4783 | $4783 |
|  Product ID Recurring Supplies, Parts & Service | 21513 | 20243 | 21492 | 20997 | 84245 | 21306 | 21306 |
|  **Total Product ID** | $**26289** | $**24754** | $**26849** | $**26329** | $**104221** | $**26089** | $**26089** |
|  **Aerospace** |  |  |  |  |  |  |  |
|  Aerospace HW | $6519 | $6425 | $7360 | $6369 | $26672 | $8992 | $8992 |
|  Aerospace Recurring Supplies, Parts & Service | 4900 | 4923 | 4960 | 4838 | 19622 | 4283 | 4283 |
|  **Total Aerospace** | $**11419** | $**11348** | $**12320** | $**11207** | $**46294** | $**13275** | $**13275** |
|  **Consolidated** |  |  |  |  |  |  |  |
|  AstroNova HW | $11295 | $10936 | $12717 | $11701 | $46648 | $13775 | $13775 |
|  AstroNova Recurring Supplies, Parts & Service | 26413 | 25166 | 26452 | 25835 | 103867 | 25589 | 25589 |
|  TOTAL | $37708 | $36102 | $39169 | $37536 | $150515 | $39364 | $39363 |

---

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 11 of 16** 

**ASTRONOVA, INC.** 

**Bookings and Backlog** 

*(Unaudited, $ in thousands)*

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **AstroNova** | **AstroNova** | **AstroNova** | **AstroNova** | **AstroNova** | **AstroNova** | **AstroNova** | **AstroNova** |
|  | **Q1 FY26** | **Q2 FY26** | **Q3 FY26** | **Q4 FY26** | **FY 2026** | **Q1 FY27** | **YTD FY2027** |
|  Backlog Beginning of Period (incl. MTEX) | $28307 | $25491 | $25291 | $21989 | $28307 | $25530 | $25530 |
|  Revenue Recognized (Billings) | $37708 | $36102 | $39169 | $37536 | $150515 | $39364 | $39364 |
|  New Bookings During Period | $34893 | $35901 | $35867 | $41077 | $147738 | $46261 | $46261 |
|  Backlog End of Period | $25491 | $25291 | $21989 | $25530 | $25530 | $32426 | $32426 |
|  Book/Bill% | 93% | 99% | 92% | 109% | 96% | 118% | 118% |
| **Product Identification** | **Product Identification** | **Product Identification** | **Product Identification** | **Product Identification** | **Product Identification** | **Product Identification** | **Product Identification** |
|  | **Q1 FY26** | **Q2 FY26** | **Q3 FY26** | **Q4 FY26** | **FY 2026** | **Q1 FY27** | **YTD FY2027** |
|  Backlog Beginning of Period (incl. MTEX) | $18091 | $18044 | $16727 | $12351 | $18091 | $13482 | $13482 |
|  Revenue Recognized (Billings) | $26289 | $24754 | $26849 | $26329 | $104221 | $26089 | $26089 |
|  New Bookings During Period | $26242 | $23437 | $22473 | $27460 | $99612 | $26789 | $26789 |
|  Backlog End of Period | $18044 | $16727 | $12351 | $13484 | $13482 | $14182 | $14182 |
|  Book/Bill% | 100% | 95% | 84% | 104% | 95% | 103% | 103% |
| **Aerospace** | **Aerospace** | **Aerospace** | **Aerospace** | **Aerospace** | **Aerospace** | **Aerospace** | **Aerospace** |
|  | **Q1 FY26** | **Q2 FY26** | **Q3 FY26** | **Q4 FY26** | **FY 2025** | **Q1 FY27** | **YTD FY2027** |
|  Backlog Beginning of Period | $10216 | $7447 | $8563 | $9638 | $10216 | $12048 | $12048 |
|  Revenue Recognized (Billings) | $11419 | $11348 | $12320 | $11207 | $46294 | $13275 | $13275 |
|  New Bookings During Period | $8651 | $12464 | $13394 | $13617 | $48126 | $19471 | $19471 |
|  Backlog End of Period | $7447 | $8563 | $9638 | $12047 | $12048 | $18244 | $18244 |
|  Book/Bill% | 76% | 110% | 109% | 122% | 97% | 147% | 147% |

---

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 12 of 16** 

**ASTRONOVA, INC.** 

**Segment Sales and Profit – Historical Quarterly Summary (Recast)** 

*(unaudited, $ in thousands)* 

---

| | | | | | | | | | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | **FY24** | **Q1** | **Q1** | **Q2** | **Q2** | **Q3** | **Q3** | **Q4** | **Q4** | **FY25** | **Q1** | **Q1** | **Q2** | **Q2** | **Q3** | **Q3** | **Q4** | **Q4** | **FY26** | **Q1 FY27** | **Q1 FY27** |
| ![LOGO](g36739dsp12a.jpg) | Revenue | $44045 |  | 9776 |  | 13374 |  | 14105 |  | 11683 | $48938 |  | 11419 |  | 11348 |  | 12320 |  | 11206 | $46294 |  | 13275 |
| ![LOGO](g36739dsp12a.jpg) | <u>Gross profit</u> | $15900 |  | 3456 |  | 5548 |  | 5093 |  | 3989 | $18087 |  | 3718 |  | 3721 |  | 6121 |  | 4236 | $17797 |  | 6022 |
| ![LOGO](g36739dsp12a.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12a.jpg) | *Gross Profit Margin* | *36.1 %* | | *35.4 %* | | *41.5 %* | | *36.1 %* | | *34.1 %* | *37.0 %* | | *32.6 %* | | *32.8 %* | | *49.7 %* | | *37.8 %* | *38.4 %* | | *45.4 %* |
| ![LOGO](g36739dsp12a.jpg) | Operating Expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12a.jpg) | Selling & Marketing | $3433 |  | 904 |  | 899 |  | 913 |  | 822 | $3537 |  | 481 |  | 911 |  | 1095 |  | 772 | $3260 |  | 903 |
| ![LOGO](g36739dsp12a.jpg) | Research & Development | $2347 |  | 801 |  | 781 |  | 877 |  | 785 | $3243 |  | 652 |  | 603 |  | 710 |  | 656 | $2621 |  | 548 |
| ![LOGO](g36739dsp12a.jpg) | <u>General & Administrative</u> | $1881 |  | 644 |  | 567 |  | 512 |  | 497 | $2220 |  | 606 |  | 540 |  | 536 |  | 471 | $2154 |  | 693 |
| ![LOGO](g36739dsp12a.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12a.jpg) | **Total Operating Expenses** | $**7661** |  | **2348** |  | **2246** |  | **2301** |  | **2104** | $**9000** |  | **1739** |  | **2055** |  | **2341** |  | **1899** | $**8034** |  | **2144** |
| ![LOGO](g36739dsp12a.jpg) | <u>**Aerospace Operating Income**</u> | $**8240** |  | **1108** |  | **3302** |  | **2792** |  | **1885** | $**9087** |  | **1979** |  | **1666** |  | **3780** |  | **2338** | $**9763** |  | **3878** |
| ![LOGO](g36739dsp12a.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12a.jpg) | Aerospace Operating Margin | 18.7% |  | 11.3% |  | 24.7% |  | 19.8% |  | 16.1% | 18.6% |  | 17.3% |  | 14.7% |  | 30.7% |  | 20.9% | 21.1% |  | 29.2% |
| ![LOGO](g36739dsp12a.jpg) | <u>*Non-GAAP*</u> |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12a.jpg) | <u>**Aerospace Adjusted EBITDA<sup>1</sup>**</u> | $**10239** |  | **1519** |  | **3719** |  | **3193** |  | **2279** | $**10710** |  | **2566** |  | **2081** |  | **3911** |  | **3104** | $**11662** |  | **3769** |
| ![LOGO](g36739dsp12a.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12a.jpg) | Adjusted EBITDA Margin<sup>1</sup> | 23.2% |  | 15.5% |  | 27.8% |  | 22.6% |  | 19.5% | 21.9% |  | 22.5% |  | 18.3% |  | 31.7% |  | 27.7% | 25.2% |  | 28.4% |
|  |  | **FY24** | **Q1** | **Q1** | **Q2** | **Q2** | **Q3** | **Q3** | **Q4** | **Q4** | **FY25** | **Q1** | **Q1** | **Q2** | **Q2** | **Q3** | **Q3** | **Q4** | **Q4** | **FY26** | **Q1 FY27** | **Q1 FY27** |
| ![LOGO](g36739dsp12b.jpg) | Revenue | $104041 |  | 23185 |  | 27165 |  | 26317 |  | 25679 | $102345 |  | 26289 |  | 24754 |  | 26849 |  | 26330 | $104221 |  | 26089 |
| ![LOGO](g36739dsp12b.jpg) | <u>Gross profit</u> | $33604 |  | 8002 |  | 8315 |  | 8015 |  | 8236 | $32570 |  | 8233 |  | 7194 |  | 7323 |  | 7088 | $29838 |  | 8403 |
| ![LOGO](g36739dsp12b.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12b.jpg) | *Gross Profit Margin* | *32.3 %* | | *34.5 %* | | *30.6 %* | | *30.5 %* | | *32.1 %* | *31.8 %* | | *31.3 %* | | *29.1 %* | | *27.3 %* | | *26.9 %* | *28.6 %* | | *32.2 %* |
| ![LOGO](g36739dsp12b.jpg) | Operating Expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12b.jpg) | Selling & Marketing | $19971 |  | 4436 |  | 5567 |  | 5438 |  | 5274 | $20715 |  | 5124 |  | 4935 |  | 4773 |  | 4870 | $19703 |  | 4789 |
| ![LOGO](g36739dsp12b.jpg) | Research & Development | $3994 |  | 670 |  | 507 |  | 795 |  | 832 | $2804 |  | 877 |  | 961 |  | 1188 |  | 1141 | $4167 |  | 1261 |
| ![LOGO](g36739dsp12b.jpg) | <u>General & Administrative</u> | $4314 |  | 1447 |  | 2363 |  | 1896 |  | 15206 | $20911 |  | 1971 |  | 1490 |  | 1667 |  | 1310 | $6439 |  | 1787 |
| ![LOGO](g36739dsp12b.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12b.jpg) | **Total Operating Expenses** | $**28280** |  | **6553** |  | **8437** |  | **8128** |  | **21312** | $**44430** |  | **7973** |  | **7387** |  | **7628** |  | **7323** | $**30310** |  | **7837** |
| ![LOGO](g36739dsp12b.jpg) | <u>**Product ID Operating Income**</u> | $**5325** |  | **1449** |  | **(121)** |  | **(112)** |  | **(13076)** | $**(11860)** |  | **260** |  | **(192)** |  | **(304)** |  | **(234)** | $**(471)** |  | **566** |
| ![LOGO](g36739dsp12b.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12b.jpg) | Product ID Operating Margin | 5.1% |  | 6.2% |  | -0.4% |  | -0.4% |  | -50.9% | -11.6% |  | 1.0% |  | -0.8% |  | -1.1% |  | -0.9% | -0.5% |  | 2.2% |
| ![LOGO](g36739dsp12b.jpg) | <u>*Non-GAAP*</u> |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12b.jpg) | **<u>Product ID Adjusted EBITDA<sup>1</sup></u>** | $**11156** |  | **2046** |  | **1619** |  | **1269** |  | **1615** | $**6550** |  | **1903** |  | **870** |  | **1371** |  | **1095** | $**5239** |  | **2112** |
| ![LOGO](g36739dsp12b.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12b.jpg) | Adjusted EBITDA Margin<sup>1</sup> | 10.7% |  | 8.8% |  | 6.0% |  | 4.8% |  | 6.3% | 6.4% |  | 7.2% |  | 3.5% |  | 5.1% |  | 4.2% | 5.0% |  | 8.1% |
|  | Corporate Expense | $4768 |  | 1211 |  | 2120 |  | 1416 |  | 1120 | $5867 |  | 1668 |  | 2181 |  | 2187 |  | 2049 | $8086 |  | 2882 |
| ![LOGO](g36739dsp12c.jpg) | **Consolidated Operating Income** | **8796** |  | **1346** |  | **1061** |  | **1264** |  | **(12311)** | **(8640)** |  | **571** |  | **(708)** |  | **1288** |  | **55** | **1207** |  | **1562** |
| ![LOGO](g36739dsp12c.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12c.jpg) | Consolidated Operating Margin | 5.9% |  | 4.1% |  | 2.6% |  | 3.1% |  | -33.0% | -5.7% |  | 1.5% |  | -2.0% |  | 3.3% |  | 0.1% | 0.8% |  | 4.0% |
| ![LOGO](g36739dsp12c.jpg) | <u>*Non-GAAP*</u> |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12c.jpg) | **<u>Adjusted EBITDA<sup>1</sup></u>** | $**17601** |  | **2463** |  | **3849** |  | **3230** |  | **2793** | $**12336** |  | **3148** |  | **2056** |  | **4173** |  | **3306** | $**12681** |  | **4122** |
| ![LOGO](g36739dsp12c.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp12c.jpg) | Adjusted EBITDA Margin<sup>1</sup> | 11.9% |  | 7.5% |  | 9.5% |  | 8.0% |  | 7.5% | 8.2% |  | 8.3% |  | 5.7% |  | 10.7% |  | 8.8% | 8.4% |  | 10.5% |

---

*<sup>1</sup>* *Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP metrics. Please refer to the reconciliation of GAAP to non-GAAP metrics in the tables that accompany this news release.* 

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 13 of 16** 

**ASTRONOVA, INC.** 

**Reconciliation of GAAP to Non-GAAP Items** 

In Thousands Except for Per Share Data

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | Three Months Ended | Three Months Ended |
|  | **April 30,<br>2026** | April 30,<br>2025 |
|  Revenue | $**39364** | $37708 |
|  Gross Profit | $**14425** | $11951 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Step-Up | **—** | 61 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Provision | **(263)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Restructuring Charges | **360** | 340 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-Recurring Legal, Professional & Other Expenses | **29** |  |
|  Non-GAAP Gross Profit | $**14552** | $12352 |
|  Gross Profit Margin | **36.6%** | 31.7% |
|  Non-GAAP Gross Profit Margin | **36.9%** | 32.8% |
|  Operating Expenses | $**12863** | $11382 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MTEX-related Acquisition Expenses | **—** | (337) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonus | **(165)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Restructuring Charges | **(2)** | (219) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-Recurring Legal, Professional & Other Expenses | **(734)** |  |
|  Non-GAAP Operating Expenses | $**11962** | $10826 |
|  Operating Income | $**1562** | $571 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MTEX-related Acquisition Expenses | **—** | 337 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Step-Up | **—** | 61 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Provision | **(263)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonus | **165** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Restructuring Charges | **362** | 558 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-Recurring Legal, Professional & Other Expenses | **763** |  |
|  Non-GAAP Operating Income | $**2589** | $1527 |
|  Operating Income Margin | **4.0%** | 1.5% |
|  Non-GAAP Operating Income Margin | **6.6%** | 4.0% |
|  Net Income (Loss) | $**653** | $(376) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MTEX-related Acquisition Expenses<sup>(1)</sup> | **—** | 257 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Step-Up<sup>(1)</sup> | **—** | 49 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Provision<sup>(1)</sup> | **(192)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonus<sup>(1)</sup> | **125** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Restructuring Charges<sup>(1)</sup> | **276** | 424 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-Recurring Legal, Professional, and Other Expenses<sup>(1)</sup> | **581** |  |
|  Non-GAAP Net Income | $**1443** | $354 |
|  Diluted Earnings (Loss) Per Share | $**0.08** | $(0.05) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MTEX-related Acquisition Expenses<sup>(1)</sup> | **—** | 0.03 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Step-Up<sup>(1)</sup> | **—** | 0.01 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventory Provision<sup>(1)</sup> | **(0.02)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonus<sup>(1)</sup> | **0.02** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Restructuring Charges<sup>(1)</sup> | **0.04** | 0.06 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-Recurring Legal, Prfessional and Other Expenses<sup>(1)</sup> | **0.07** |  |
|  Non-GAAP Diluted Earnings Per Share | $**0.19** | $0.05 |

---

<sup>(1)</sup> Net of taxes

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 14 of 16** 

**ASTRONOVA, INC.** 

**Reconciliation of Net Income (Loss) to Adjusted EBITDA** 

Amounts In Thousands

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **April 30, 2026** | April 30, 2025 |
|  Net Income (Loss) | $**653** | $(376) |
|  Interest Expense | **675** | 897 |
|  Income Tax Expense | **196** | 75 |
|  Depreciation & Amortization | **1182** | 1290 |
|  EBITDA | $**2706** | $1886 |
|  Share-Based Compensation | **389** | 306 |
|  Bonus | **165** |  |
|  MTEX-related Acquisition Expenses | **—** | 337 |
|  Inventory Step-Up | **—** | 61 |
|  Inventory Provision | **(263)** |  |
|  Restructuring Charges | **362** | 558 |
|  Non-Recurring Legal Expenses | **763** |  |
|  Adjusted EBITDA | $**4122** | $3148 |
|  Revenue | $**39364** | $37708 |
|  Net Income (Loss) Margin | **1.7%** | (1.0)% |
|  Adjusted EBITDA Margin | **10.5%** | 8.3% |

---

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 15 of 16** 

**ASTRONOVA, INC.** 

**Reconciliation of Segment Gross Profit to Non-GAAP Segment Gross Profit and Margin** 

Amounts In Thousands

(Unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
|  | **April 30, 2026** | **April 30, 2026** | **April 30, 2026** | April 30, 2025 | April 30, 2025 | April 30, 2025 |
|  | **Product<br>ID** | **Aerospace** | **Total** | Product<br>ID | Aerospace | Total |
|  Segment Gross Profit | $**8403** | $**6022** | $**14425** | $8233 | $3718 | $11951 |
|  Inventory Step-Up | **—** | **—** | **—** | 61 |  | 61 |
|  Inventory Provision | **232** | **(495)** | **(263)** |  |  |  |
|  Restructuring Charges | **360** | **—** | **360** | 171 | 169 | 340 |
|  Non-Recurring Legal, Professional & Other Expenses | **29** | **—** | **29** |  |  |  |
|  Non-GAAP - Segment Gross Profit | $**9023** | $**5527** | $**14551** | $8465 | $3887 | $12352 |
|  Revenue | $**26089** | $**13275** | $**39364** | $26289 | $11419 | $37708 |
|  Gross Profit Margin | **32.2%** | **45.4%** | **36.6%** | 31.3% | 32.6% | 31.7% |
|  Non-GAAP Segment Gross Profit Margin | **34.6%** | **41.6%** | **36.9%** | 32.2% | 34.0% | 32.8% |

---

**ASTRONOVA, INC.** 

**Reconciliation of Segment Operating Profit and Margin to Non-GAAP Operating Profit and Margin** 

Amounts In Thousands

(Unaudited)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
|  | **April 30, 2026** | **April 30, 2026** | **April 30, 2026** | April 30, 2025 | April 30, 2025 | April 30, 2025 |
|  | **Product<br>ID** | **Aerospace** | **Total** | Product<br>ID | Aerospace | Total |
|  Segment Operating Income | $**566** | $**3878** | $**4444** | $260 | $1979 | $2239 |
|  Inventory Step-Up | **—** | **—** | **—** | 61 |  | 61 |
|  Inventory Provision | **232** | **(495)** | **(263)** |  |  |  |
|  Bonus | **60** | **10** | **70** |  |  |  |
|  Restructuring Charges | **362** | **—** | **362** | 339 | 171 | 510 |
|  MTEX-related Acquisition Expenses | **—** | **—** | **—** | 336 |  | 336 |
|  Non-Recurring Legal, Professional & Other Expenses | **43** | **—** | **43** |  |  |  |
|  Non-GAAP - Segment Operating Income | $**1263** | $**3393** | $**4656** | $995 | $2150 | $3145 |
|  Revenue | $**26089** | $**13275** | $**39364** | $26289 | $11419 | $37708 |
|  Operating Margin | **2.2%** | **29.2%** | **11.3%** | 1.0% | 17.3% | 5.9% |
|  Non-GAAP Operating Margin | **4.8%** | **25.6%** | **11.8%** | 3.8% | 18.8% | 8.3% |

---

------

**AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027** 

**June 8, 2026** 

 **Page 16 of 16** 

**ASTRONOVA INC.** 

**Reconciliation of Segment and Consolidated Net Income to Adjusted EBITDA (Past Quarters and Years)** 

*(Unaudited, $ in thousands)* 

---

| | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | **2024** | **Q1 25** | **Q2 25** | **Q3 25** | **Q4 25** | **FY25** | **Q1 26** | **Q2 26** | **Q3 26** | **Q4 26** | **FY26** | **Q1 27** |
| ![LOGO](g36739dsp16.jpg) | **Operating Income** | $**8240** | $**1108** | $**3302** | $**2792** | $**1886** | $**9088** | $**1980** | $**1666** | $**3780** | $**2338** | $**9763** | $**3878** |
| ![LOGO](g36739dsp16.jpg) | Other |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16.jpg) | Interest expense |  |  |  |  |  |  |  |  |  |  |  | 15 |
| ![LOGO](g36739dsp16.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16.jpg) | Profit Before Tax | $8240 | 1108 | 3302 | 2792 | 1886 | $9088 | 1980 | 1666 | 3780 | 2338 | $9763 | $3863 |
| ![LOGO](g36739dsp16.jpg) | Tax |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16.jpg) | **Net Income** | $**8240** | **1108** | **3302** | **2792** | **1886** | $**9088** | **1980** | **1666** | **3780** | **2338** | $**9763** | $**3863** |
| ![LOGO](g36739dsp16.jpg) | Interest expense |  |  |  |  |  |  |  |  |  |  |  | 15 |
| ![LOGO](g36739dsp16.jpg) | Tax |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16.jpg) | Depreciation & Amortization | 1873 | 374 | 378 | 365 | 365 | 1482 | 373 | 368 | 363 | 360 | 1464 | 332 |
| ![LOGO](g36739dsp16.jpg) | Share-Based Compensation | 126 | 37 | 39 | 36 | 29 | 140 | 43 | 46 | 80 | 94 | 263 | 44 |
| ![LOGO](g36739dsp16.jpg) | Bonus |  |  |  |  |  |  |  |  |  |  |  | 10 |
| ![LOGO](g36739dsp16.jpg) | Inventory Provision |  |  |  |  |  |  |  |  | (311) | 311 |  | (495) |
| ![LOGO](g36739dsp16.jpg) | Restructuring Charges |  |  |  |  |  |  | 170 | 1 |  |  | 171 |  |
| ![LOGO](g36739dsp16.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16.jpg) | **Adjusted EBITDA** | $**10239** | $**1519** | $**3719** | $**3193** | $**2279** | $**10710** | $**2566** | $**2081** | $**3911** | $**3104** | $**11662** | $**3769** |
| ![LOGO](g36739dsp16.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16.jpg) | Revenue | $44045 | $9776 | $13374 | $14105 | $11683 | $48938 | $11419 | $11348 | $12320 | $11206 | $46294 | $13275 |
| ![LOGO](g36739dsp16.jpg) | Adjusted EBITDA Margin | 23.2% | 15.5% | 27.8% | 22.6% | 19.5% | 21.9% | 22.5% | 18.3% | 31.7% | 27.7% | 25.2% | 28.4% |
|  |  | **2024** | **Q1 25** | **Q2 25** | **Q3 25** | **Q4 25** | **FY25** | **Q1 26** | **Q2 26** | **Q3 26** | **Q4 26** | **FY26** | **Q1 27** |
| ![LOGO](g36739dsp16a.jpg) | **Operating Income** | $**5325** | $**1449** | $**(121)** | $**(113)** | $**(13075)** | $**(11860)** | $**260** | $**(192)** | $**(304)** | $**(234)** | $**(470)** | $**566** |
| ![LOGO](g36739dsp16a.jpg) | Other |  |  |  |  |  |  |  |  |  |  |  | 20 |
| ![LOGO](g36739dsp16a.jpg) | Interest expense |  |  |  |  |  |  |  |  |  |  |  | 24 |
| ![LOGO](g36739dsp16a.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16a.jpg) | Profit Before Tax | $5325 | 1449 | (121) | (113) | (13075) | $(11860) | 260 | (192) | (304) | (234) | $(470) | $522 |
| ![LOGO](g36739dsp16a.jpg) | Tax |  |  |  |  |  |  |  |  |  |  |  | 364 |
| ![LOGO](g36739dsp16a.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16a.jpg) | **Net Income** | $**5325** | **1449** | **(121)** | **(113)** | **(13075)** | $**(11860)** | **260** | **(192)** | **(304)** | **(234)** | $**(470)** | $**158** |
| ![LOGO](g36739dsp16a.jpg) | Interest expense |  |  |  |  |  |  |  |  |  |  |  | 24 |
| ![LOGO](g36739dsp16a.jpg) | Tax |  |  |  |  |  |  |  |  |  |  |  | 364 |
| ![LOGO](g36739dsp16a.jpg) | Depreciation & Amortization | 2378 | 532 | 921 | 929 | 896 | 3279 | 913 | 909 | 489 | 1013 | 3322 | 844 |
| ![LOGO](g36739dsp16a.jpg) | Share-Based Compensation | 317 | 64 | 74 | 94 | 75 | 308 | (7) | 86 | 88 | 207 | 373 | 26 |
| ![LOGO](g36739dsp16a.jpg) | Bonus |  |  |  |  |  |  |  |  |  |  |  | 60 |
| ![LOGO](g36739dsp16a.jpg) | MTEX-related Acquisition Expenses |  |  | 625 | 325 | 254 | 1204 | 337 | (26) |  |  | 311 |  |
| ![LOGO](g36739dsp16a.jpg) | Inventory Step-Up |  |  | 120 | 34 | 62 | 216 | 61 |  |  |  | 61 |  |
| ![LOGO](g36739dsp16a.jpg) | Inventory Provision |  |  |  |  |  |  |  |  | 670 | 54 | 724 | 232 |
| ![LOGO](g36739dsp16a.jpg) | Restructuring Charges | 2494 |  |  |  |  |  | 339 | 94 | (2) | 52 | 483 | 362 |
| ![LOGO](g36739dsp16a.jpg) | Product Retrofit Costs | 642 |  |  |  |  |  |  |  |  | 185 | 185 |  |
| ![LOGO](g36739dsp16a.jpg) | Non-Recurring Legal Expenses |  |  |  |  |  |  |  |  | 134 | (182) | (48) | 43 |
| ![LOGO](g36739dsp16a.jpg) | Goodwill Impairment |  |  |  |  | 13403 | 13403 |  |  | 297 |  | 297 |  |
| ![LOGO](g36739dsp16a.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16a.jpg) | **Adjusted EBITDA** | $**11156** | $**2046** | $**1619** | $**1269** | $**1615** | $**6550** | $**1903** | $**870** | $**1371** | $**1095** | $**5239** | $**2112** |
| ![LOGO](g36739dsp16a.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16a.jpg) | Revenue | $104041 | $23185 | $27165 | $26317 | $25679 | $102345 | $26289 | $24754 | $26849 | $26330 | $104221 | $26089 |
|  | Adjusted EBITDA Margin | 10.7% | 8.8% | 6.0% | 4.8% | 6.3% | 6.4% | 7.2% | 3.5% | 5.1% | 4.2% | 5.0% | 8.1% |
|  |  | **2024** | **Q1 25** | **Q2 25** | **Q3 25** | **Q4 25** | **FY25** | **Q1 26** | **Q2 26** | **Q3 26** | **Q4 26** | **FY26** | **Q1 27** |
| ![LOGO](g36739dsp16b.jpg) | **Operating Income** | $**(4768)** | $**(1211)** | $**(2120)** | $**(1416)** | $**(1122)** | $**(5869)** | $**(1668)** | $**(2181)** | $**(2187)** | $**(2050)** | $**(8087)** | $**(2882)** |
| ![LOGO](g36739dsp16b.jpg) | Other | 26 | 118 | 173 | 46 | 100 | 437 | (24) | 104 | 210 | (51) | 239 | 18 |
| ![LOGO](g36739dsp16b.jpg) | Interest expense | 2697 | 482 | 938 | 944 | 847 | 3210 | 897 | 885 | 827 | 894 | 3503 | 635 |
| ![LOGO](g36739dsp16b.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16b.jpg) | Profit Before Tax | $(7491) | (1811) | (3231) | (2406) | (2069) | $(9516) | (2541) | (3170) | (3224) | (2893) | $(11829) | $(3536) |
| ![LOGO](g36739dsp16b.jpg) | Tax | 1379 | (434) | 261 | 34 | 2342 | 2203 | 75 | (454) | (128) | 346 | (161) | (168) |
| ![LOGO](g36739dsp16b.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16b.jpg) | **Net Income** | $**(8870)** | **(1377)** | **(3492)** | **(2440)** | **(4411)** | $**(11719)** | **(2616)** | **(2716)** | **(3096)** | **(3239)** | $**(11668)** | $**(3368)** |
| ![LOGO](g36739dsp16b.jpg) | Interest expense | 2697 | 482 | 938 | 944 | 847 | 3210 | 897 | 885 | 827 | 894 | 3503 | 635 |
| ![LOGO](g36739dsp16b.jpg) | Tax | 1379 | (434) | 261 | 36 | 2342 | 2205 | 75 | (454) | (128) | 346 | (161) | (168) |
| ![LOGO](g36739dsp16b.jpg) | Depreciation & Amortization | 15 | 4 | 4 | 6 | 4 | 19 | 4 | 4 | 5 | 5 | 18 | 6 |
| ![LOGO](g36739dsp16b.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16b.jpg) | **EBITDA** | $**(4779)** | **(1324)** | **(2289)** | **(1454)** | **(1218)** | $**(6285)** | **(1640)** | **(2282)** | **(2392)** | **(1994)** | $**(8308)** | $**(2894)** |
| ![LOGO](g36739dsp16b.jpg) | Share-Based Compensation | 903 | 223 | 368 | 222 | 116 | 929 | 270 | 367 | 586 | 449 | 1673 | 318 |
| ![LOGO](g36739dsp16b.jpg) | Bonus |  |  |  |  |  |  |  |  |  |  |  | 95 |
| ![LOGO](g36739dsp16b.jpg) | CFO Transition Costs |  |  | 432 |  |  | 432 |  |  |  |  |  |  |
| ![LOGO](g36739dsp16b.jpg) | Restructuring Charges | 82 |  |  |  |  |  | 49 | 595 | 60 |  | 703 | 0 |
| ![LOGO](g36739dsp16b.jpg) | Non-Recurring Legal Expenses |  |  |  |  |  |  |  | 69 | 254 | 440 | 763 | 720 |
| ![LOGO](g36739dsp16b.jpg) | Non-Recurring Proxy Costs |  |  |  |  |  |  |  | 355 | 172 | 210 | 738 |  |
| ![LOGO](g36739dsp16b.jpg) | Realized Fx |  |  |  |  |  |  |  |  | 100 |  | 100 |  |
| ![LOGO](g36739dsp16b.jpg) | Other (Income) and Expense |  |  |  |  |  |  |  |  | 112 |  | 112 |  |
| ![LOGO](g36739dsp16b.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16b.jpg) | **Adjusted EBITDA** | $**(3794)** | $**(1101)** | $**(1489)** | $**(1232)** | $**(1102)** | $**(4924)** | $**(1321)** | $**(896)** | $**(1108)** | $**(895)** | $**(4220)** | $**(1760)** |
|  |  | **2024** | **Q1 25** | **Q2 25** | **Q3 25** | **Q4 25** | **FY25** | **Q1 26** | **Q2 26** | **Q3 26** | **Q4 26** | **FY26** | **Q1 27** |
| ![LOGO](g36739dsp16c.jpg) | **Operating Income** | $**8796** | $**1346** | $**1061** | $**1263** | $**(12311)** | $**(8641)** | $**572** | $**(708)** | $**1288** | $**55** | $**1208** | $**1562** |
| ![LOGO](g36739dsp16c.jpg) | Other | 26 | 118 | 173 | 46 | 100 | 437 | (24) | 104 | 210 | (51) | 239 | 38 |
| ![LOGO](g36739dsp16c.jpg) | Interest expense | 2697 | 482 | 938 | 944 | 847 | 3210 | 897 | 885 | 827 | 894 | 3503 | 675 |
| ![LOGO](g36739dsp16c.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16c.jpg) | Profit Before Tax | $6073 | 746 | (50) | 273 | (13258) | $(12288) | (301) | (1697) | 251 | (789) | $(2535) | $849 |
| ![LOGO](g36739dsp16c.jpg) | Tax | 1379 | (434) | 261 | 34 | 2342 | 2202 | 75 | (454) | (128) | 346 | (161) | 196 |
| ![LOGO](g36739dsp16c.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16c.jpg) | **Net Income** | $4694 | 1180 | (311) | 239 | (15600) | $(14490) | (376) | (1243) | 379 | (1134) | $(2373) | $653 |
| ![LOGO](g36739dsp16c.jpg) | Interest expense | 2697 | 482 | 938 | 944 | 847 | 3210 | 897 | 885 | 827 | 894 | 3503 | 675 |
| ![LOGO](g36739dsp16c.jpg) | Tax | 1379 | (434) | 261 | 36 | 2342 | 2202 | 75 | (454) | (128) | 346 | (161) | 196 |
| ![LOGO](g36739dsp16c.jpg) | Depreciation & Amortization | 4266 | 911 | 1304 | 1300 | 1266 | 4780 | 1290 | 1280 | 856 | 1379 | 4805 | 1182 |
| ![LOGO](g36739dsp16c.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16c.jpg) | **EBITDA** | $**13036** | **2139** | **2191** | **2519** | **(11146)** | $**(4297)** | **1886** | **469** | **1934** | **1485** | $**5774** | $**2706** |
| ![LOGO](g36739dsp16c.jpg) | Share-Based Compensation | 1347 | 325 | 481 | 352 | 219 | 1378 | 306 | 499 | 754 | 751 | 2310 | 389 |
| ![LOGO](g36739dsp16c.jpg) | Bonus |  |  |  |  |  |  |  |  |  |  |  | 165 |
| ![LOGO](g36739dsp16c.jpg) | MTEX-related Acquisition Expenses |  |  | 625 | 325 | 254 | 1204 | 337 | (26) |  |  | 311 |  |
| ![LOGO](g36739dsp16c.jpg) | CFO Transition Costs |  |  | 432 |  |  | 432 |  |  |  |  |  |  |
| ![LOGO](g36739dsp16c.jpg) | Inventory Step-Up |  |  | 120 | 34 | 62 | 216 | 61 |  |  |  | 61 |  |
| ![LOGO](g36739dsp16c.jpg) | Inventory Provision |  |  |  |  |  |  |  |  | 359 | 365 | 724 | (264) |
| ![LOGO](g36739dsp16c.jpg) | Restructuring Charges | 2576 |  |  |  |  |  | 558 | 689 | 59 | 52 | 1357 | 362 |
| ![LOGO](g36739dsp16c.jpg) | Product Retrofit Costs | 642 |  |  |  |  |  |  |  |  | 185 | 185 |  |
| ![LOGO](g36739dsp16c.jpg) | Non-Recurring Legal Expenses |  |  |  |  |  |  |  | 69 | 387 | 258 | 715 | 763 |
| ![LOGO](g36739dsp16c.jpg) | Non-Recurring Proxy Costs |  |  |  |  |  |  |  | 355 | 172 | 210 | 738 |  |
| ![LOGO](g36739dsp16c.jpg) | Realized Fx |  |  |  |  |  |  |  |  | 100 |  | 100 |  |
| ![LOGO](g36739dsp16c.jpg) | Other (Income) and Expense |  |  |  |  |  |  |  |  | 112 |  | 112 |  |
| ![LOGO](g36739dsp16c.jpg) | Goodwill Impairment |  |  |  |  | 13403 | 13403 |  |  | 297 |  | 297 |  |
| ![LOGO](g36739dsp16c.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16c.jpg) | **Adjusted EBITDA** | $**17601** | $**2463** | $**3849** | $**3230** | $**2793** | $**12336** | $**3149** | $**2056** | $**4175** | $**3306** | $**12682** | $**4121** |
| ![LOGO](g36739dsp16c.jpg) |  |  |  |  |  |  |  |  |  |  |  |  |  |
| ![LOGO](g36739dsp16c.jpg) | Revenue | $148086 | $32961 | $40539 | $40422 | $37361 | $151283 | $37708 | $36102 | $39169 | $37536 | $150515 | $39364 |
| ![LOGO](g36739dsp16c.jpg) | Adjusted EBITDA Margin | 11.9% | 7.5% | 9.5% | 8.0% | 7.5% | 8.2% | 8.4% | 5.7% | 10.7% | 8.8% | 8.4% | 10.5% |

---